Medpace 

$339.38
115
+$3.64+1.08% Monday 20:00

Statistik

Harga Tertinggi Hari
342.56
Harga Terendah Hari
335.66
52M Tertinggi
459.77
52M Terendah
227.21
Volum
318,423
Volum Purata
266,090
Kapasiti Pasaran
11.01B
Nisbah P/E
33.45
Pendapatan Dividen
-
Dividen
-

Akan Datang

Pendapatan

21OctDijangka
Q1 2023
Q2 2023
Q3 2023
Q4 2023
Q1 2024
Q2 2024
Seterusnya
1.8
2.27
2.73
3.2
EPS yang dijangka
2.794971
EPS sebenar
N/A

Orang Lain Juga Mengikuti

Senarai ini berdasarkan senarai pantau orang di Stock Events yang mengikuti MEDP. Ini bukan cadangan pelaburan.

Peserta

Senarai ini adalah analisis berdasarkan peristiwa pasaran terkini. Ini bukan cadangan pelaburan.

Penilaian Penganalisis

418.86$Sasaran Harga Purata
Anggaran tertinggi adalah $450.
Dari 8 penilaian dalam tempoh 6 bulan terakhir. Ini bukan cadangan pelaburan.
Beli
75%
Pegang
25%
Jual
0%

Mengenai

Commercial Services
Miscellaneous Commercial Services
Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. It offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. The company also provides clinical development services to the pharmaceutical, biotechnology, and medical device industries; and development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support services. In addition, it offers bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials. The company was founded in 1992 and is based in Cincinnati, Ohio.
Show more...
CEO
August Troendle
Pekerja
5800
Negara
US
ISIN
US58506Q1094

Penyenaraian